Literature DB >> 18340547

In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY).

X Z Wang1, B Fan, L G Liu, X Y Hu, R Y Li, Y Wei, Z Wan, X L Deng.   

Abstract

This study was conducted to measure Candida albicans-specific chicken egg yolk antibody (IgY) inhibition of fluconazole-sensitive and resistant strains of C. albicans in order to assess potential use in the prevention and treatment of oral candidiasis. In this study, laying hens were immunized, and IgY was extracted by water dilution. The Minimal Inhibitory Concentrations (MICs) of IgY for inhibiting C. albicans growth were determined using the broth microdilution method from the CLSI M27-A2 protocol. Fluconazole (FLC) was used as the control. The results were analyzed with the chi(2) test. The anti-Candida titer of anti-C. albicans IgY was 1:12,000. The concentration of the IgY extract that effectively inhibited the growth of C. albicans was between 1.25 g/l and 5.0 g/l, and the efficacy rate was 82.98% during the observed 24-48 h time period. No correlation was recorded between the drug resistance of FLC and growth inhibition by IgY. It was concluded that anti-C. albicans IgY inhibited the growth of C. albicans in vitro and there was no correlation between the drug resistance of FLC and the growth inhibition by IgY (P > 0.99).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340547     DOI: 10.1007/s11046-008-9097-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  22 in total

1.  Efficient production of chicken egg yolk antibodies against a conserved mammalian protein.

Authors:  M Gassmann; P Thömmes; T Weiser; U Hübscher
Journal:  FASEB J       Date:  1990-05       Impact factor: 5.191

2.  Oral yeast carriage in patients with advanced cancer.

Authors:  A N Davies; S Brailsford; K Broadley; D Beighton
Journal:  Oral Microbiol Immunol       Date:  2002-04

3.  Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish.

Authors:  Lucio Milillo; Lorenzo Lo Muzio; Paolo Carlino; Rosario Serpico; Ermina Coccia; Crispian Scully
Journal:  Int J Prosthodont       Date:  2005 Jan-Feb       Impact factor: 1.681

4.  A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors:  María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

5.  Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG.

Authors:  H Hatta; K Tsuda; S Akachi; M Kim; T Yamamoto
Journal:  Biosci Biotechnol Biochem       Date:  1993-03       Impact factor: 2.043

6.  Acid stability of anti-Helicobacter pyroli IgY in aqueous polyol solution.

Authors:  Kyong Ae Lee; Sung Keun Chang; Yoon Jin Lee; Jong Hwa Lee; Nan Sook Koo
Journal:  J Biochem Mol Biol       Date:  2002-09-30

Review 7.  Denture stomatitis: a review.

Authors:  T M Arendorf; D M Walker
Journal:  J Oral Rehabil       Date:  1987-05       Impact factor: 3.837

8.  Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying enteropathogenic Escherichia coli.

Authors:  C M C de Almeida; V M Quintana-Flores; E Medina-Acosta; A Schriefer; M Barral-Netto; W Dias da Silva
Journal:  Scand J Immunol       Date:  2003-06       Impact factor: 3.487

9.  Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.

Authors:  S Kariyawasam; B N Wilkie; C L Gyles
Journal:  Vet Microbiol       Date:  2004-03-05       Impact factor: 3.293

10.  Anti-peptide immunoglobulins from rabbit and chicken eggs recognise recombinant human dihydroorotate dehydrogenase and a 44-kDa protein from rat liver mitochondria.

Authors:  W Knecht; R Köhler; M Minét; M Löffler
Journal:  Eur J Biochem       Date:  1996-03-01
View more
  2 in total

1.  Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.

Authors:  Ashley L Fink; Katherine L Williams; Eva Harris; Travis D Alvine; Thomas Henderson; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

Review 2.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.